James Joyce's Biography

James Joyce, Chairman & CEO, Aethlon Medical, Inc.

Mr. Joyce is the founder, Chairman and Chief Executive Officer of Aethlon Medical, a publicly traded developer of immunotherapeutic technologies to combat infectious disease and cancer. Mr. Joyce is also the Executive Chairman of Exosome Sciences, a majority-owned subsidiary of Aethlon Medical that is focused on the discovery of exosomal biomarkers to diagnose and monitor life-threatening diseases.

Therapeutic and Diagnostic Targeting of Exosomes in Cancer and Infectious Disease

Friday, 30 September 2016 at 12:00

Add to Calendar ▼2016-09-30 12:00:002016-09-30 13:00:00Europe/LondonTherapeutic and Diagnostic Targeting of Exosomes in Cancer and Infectious DiseaseLiquid Biopsies and Minimally-Invasive Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com

Discussion of lectin-affinity techniques to eliminate disease-promoting exosomes from circulation and the isolation of exosomal biomarkers from bodily fluids.

Add to Calendar ▼2016-09-29 00:00:002016-09-30 00:00:00Europe/LondonLiquid Biopsies and Minimally-Invasive Diagnostics 2016Liquid Biopsies and Minimally-Invasive Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com

#LBP2016 Tweets

Corporate Sponsors

	Emerging Technologies for Diagnostics & Liquid Biopsies - New Orleans 2024 Location: New Orleans Date: 26/09/2024 - 27/09/2024

	Innovations in Microfluidics 2024: Rapid Prototyping, 3D-Printing Location: Ann Arbor, Michigan Date: 06/05/2024 - 07/05/2024

	Lab-on-a-Chip and Microfluidics Europe 2024 Location: Rotterdam, The Netherlands Date: 24/06/2024 - 25/06/2024